Clinical Trial Update: Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism [NA]

View source ↗

Summary

A clinical trial evaluated intermittent calorie restriction in MASLD patients with abnormal glucose metabolism; results were posted in September 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease
• Prediabetes
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Fatty Liver Disease, Type 2 Diabetes | NA | Status: COMPLETED | Results posted: 2024-09-23